{"componentChunkName":"component---src-templates-chapter-level-2-chapter-level-2-tsx","path":"/topics/urinary-tract-infection-children/management/recurrent-uti-in-children/","result":{"pageContext":{"chapter":{"id":"47d251fa-94da-5df5-889b-aec47b266935","slug":"recurrent-uti-in-children","fullItemName":"Scenario: Recurrent UTI in children","depth":2,"htmlHeader":"<!-- begin field ad323da9-946f-4b52-b08b-a9ed010ec400 --><h2>Scenario: Managing recurrent urinary tract infection in children</h2><!-- end field ad323da9-946f-4b52-b08b-a9ed010ec400 -->","summary":"Covers the management of children with recurrent urinary tract infection.","htmlStringContent":"<!-- begin item a288b583-cd4e-4897-aee2-a9ed010ec3c4 --><!-- begin field 2dcaa1e0-5f8d-46ff-b098-acbc015a7362 --><p>From birth to 16 years.</p><!-- end field 2dcaa1e0-5f8d-46ff-b098-acbc015a7362 --><!-- end item a288b583-cd4e-4897-aee2-a9ed010ec3c4 -->","topic":{"id":"991f627d-8926-57b4-aaf8-67af4fd5db9d","topicId":"510a3aa0-27ac-462a-a52b-fe6491d08ab0","topicName":"Urinary tract infection - children","slug":"urinary-tract-infection-children","lastRevised":"Last revised in February 2019","chapters":[{"id":"d1ecfd05-b7d6-5f26-958b-08cbc3d78492","fullItemName":"Summary","slug":"summary","subChapters":[]},{"id":"5867e1c1-3817-541e-8b04-bef811c2f6c4","fullItemName":"Have I got the right topic?","slug":"have-i-got-the-right-topic","subChapters":[]},{"id":"79d4f794-da69-53db-a658-5ce7c959f692","fullItemName":"How up-to-date is this topic?","slug":"how-up-to-date-is-this-topic","subChapters":[{"id":"2f77533f-9993-5dbe-aec4-d0ee486a2559","slug":"changes","fullItemName":"Changes"},{"id":"79054143-84a5-50b1-8bcd-34d7ea4ff7da","slug":"update","fullItemName":"Update"}]},{"id":"26055421-3310-5e60-9152-68faccc1b450","fullItemName":"Goals and outcome measures","slug":"goals-outcome-measures","subChapters":[{"id":"2e0770ba-47ca-5e33-8ed4-cc1f3f27b080","slug":"goals","fullItemName":"Goals"},{"id":"9b22c988-34f6-555d-9dc3-8ab3bb093e3a","slug":"outcome-measures","fullItemName":"Outcome measures"},{"id":"fe1b7a61-e520-56e2-be30-8608881cdb7f","slug":"audit-criteria","fullItemName":"Audit criteria"},{"id":"2b6a45d0-fdcd-5821-864d-63a74db81d6a","slug":"qof-indicators","fullItemName":"QOF indicators"},{"id":"e6f051e1-15a3-55a3-be65-2a623b2dae1c","slug":"qipp-options-for-local-implementation","fullItemName":"QIPP - Options for local implementation"},{"id":"8b4bab45-57e8-59b8-bd66-9036dc2fc571","slug":"nice-quality-standards","fullItemName":"NICE quality standards"}]},{"id":"dd9ffb6c-bd87-54d5-8c87-1e080e01ea4b","fullItemName":"Background information","slug":"background-information","subChapters":[{"id":"1136e250-9882-5b2e-a75c-91e52993494f","slug":"definition","fullItemName":"Definition"},{"id":"45b0687c-19a3-5dc0-a5aa-e56c1e8d1061","slug":"causal-organisms","fullItemName":"Causal organisms"},{"id":"003daae9-bb06-5297-8ac5-cabcf10e7968","slug":"prevalence","fullItemName":"Prevalence"},{"id":"750a5b3e-7655-5653-bd66-cbf33a4daffe","slug":"risk-factors","fullItemName":"Risk factors"},{"id":"2d85acf8-d02b-5815-bb49-4c5f17b8678f","slug":"prognosis","fullItemName":"Prognosis"},{"id":"9f9d006d-bcda-5469-81d7-d2c3123c99d4","slug":"complications","fullItemName":"Complications"}]},{"id":"0bd6000e-bd4c-5f90-a711-bd23da73865d","fullItemName":"Diagnosis","slug":"diagnosis","subChapters":[{"id":"8f91b779-7c82-5647-b2f7-d8c90726d303","slug":"suspecting-a-urinary-tract-infection","fullItemName":"Suspecting a urinary tract infection"},{"id":"5e82d0e6-4bfb-58c7-955f-7d2bc44d7ff6","slug":"diagnosing-a-urinary-tract-infection","fullItemName":"Diagnosing a urinary tract infection"},{"id":"57282b06-7213-5787-8603-4673c4ead4c4","slug":"differential-diagnosis","fullItemName":"Differential diagnosis"}]},{"id":"d3a08393-35d5-53dc-935a-d5e32abee30b","fullItemName":"Management","slug":"management","subChapters":[{"id":"732454b5-6086-54ad-8fe0-68d4d8c9b5f8","slug":"uti-in-children","fullItemName":"Scenario: UTI in children"},{"id":"47d251fa-94da-5df5-889b-aec47b266935","slug":"recurrent-uti-in-children","fullItemName":"Scenario: Recurrent UTI in children"}]},{"id":"fcc5959a-b3b9-5135-9a34-0567f5ec597e","fullItemName":"Prescribing information","slug":"prescribing-information","subChapters":[{"id":"49e814b6-1bc7-5c87-91e7-ea6edc49413f","slug":"trimethoprim","fullItemName":"Trimethoprim"},{"id":"178d0dc1-f68e-5c02-8ab6-590182cdb89b","slug":"nitrofurantoin","fullItemName":"Nitrofurantoin"},{"id":"f0eecb36-6697-52c3-ba61-43722573d661","slug":"cefalexin","fullItemName":"Cefalexin"},{"id":"32a374c4-43e1-56a3-bc3a-3750191e085c","slug":"amoxicillin","fullItemName":"Amoxicillin"}]},{"id":"8b665f09-70b4-5fb0-a6c8-77c4766fc268","fullItemName":"Supporting evidence","slug":"supporting-evidence","subChapters":[]},{"id":"1d405e7c-5e75-5615-8deb-94bb5f1d64cb","fullItemName":"How this topic was developed","slug":"how-this-topic-was-developed","subChapters":[{"id":"82284d2f-4c04-573e-861c-5f030553a063","slug":"search-strategy","fullItemName":"Search strategy"},{"id":"27e92d92-08e0-5fd8-aa0b-a5d456171c04","slug":"stakeholder-engagement","fullItemName":"Stakeholder engagement"},{"id":"3afd108c-e35b-5034-9573-81cf33f52df5","slug":"evidence-exclusion-criteria","fullItemName":"Evidence exclusion criteria"},{"id":"ce068350-baea-5cb3-9040-ab2a90e020f8","slug":"organizational-behavioural-financial-barriers","fullItemName":"Organizational, behavioural and financial barriers"},{"id":"e6c46138-9934-5c77-9727-4d36f784738d","slug":"declarations-of-interest","fullItemName":"Declarations of interest"}]},{"id":"46eac86e-96b0-524a-ac9a-887b17be1e1c","fullItemName":"References","slug":"references","subChapters":[]}]},"parentChapter":{"id":"d3a08393-35d5-53dc-935a-d5e32abee30b","slug":"management","fullItemName":"Management"},"subChapters":[{"id":"948a862b-748d-51e4-81e2-4e3bf1e50603","slug":"managing-recurrent-uti-in-children","fullItemName":"Managing recurrent UTI in children","depth":3,"htmlHeader":"<!-- begin field 2f503a7e-6bc4-4adc-8bc9-a9ed010ec405 --><h3>How should I manage recurrent UTI in children?</h3><!-- end field 2f503a7e-6bc4-4adc-8bc9-a9ed010ec405 -->","summary":null,"htmlStringContent":"<!-- begin item b643f987-2e69-47c2-ab8c-a9ed010ec404 --><!-- begin field 3f69d0c8-10e4-4048-a12f-a9ed010ec405 --><ul><li><strong>Recurrent urinary tract infection (UTI) is defined as:</strong><ul><li>Two or more episodes of UTI with acute pyelonephritis/upper urinary tract infection, <em>or </em></li><li>One episode of UTI with acute pyelonephritis/upper urinary tract infection plus one or more episode of UTI with cystitis/lower urinary tract infection, <em>or </em></li><li>Three or more episodes of UTI with cystitis/lower urinary tract infection.</li></ul></li><li><strong>If the child has been assessed at high <a class=\"topic-reference internal-reference\" href=\"/topics/urinary-tract-infection-children/diagnosis/diagnosing-a-urinary-tract-infection/#risk-of-serious-illness\">risk of serious illness</a>, refer urgently to secondary care.</strong></li><li><strong>If UTI is suspected in children aged under 3 months — refer urgently to a paediatric specialist for treatment with parenteral antibiotics, and send a urine sample for urgent microscopy and culture. </strong></li><li><strong>For children aged 3 months or over with recurrent UTI, ensure that any current UTI has been adequately <a class=\"topic-reference internal-reference\" href=\"/topics/urinary-tract-infection-children/management/uti-in-children/#managing-urinary-tract-infection\">treated</a>, then take specialist advice and consider a trial of daily <a class=\"topic-reference internal-reference\" href=\"/topics/urinary-tract-infection-children/management/recurrent-uti-in-children/#antibiotic-prophylaxis\">antibiotic prophylaxis</a>, if behavioural and personal hygiene measures alone are not effective or not appropriate</strong>. Take account of:<ul><li>Underlying causes following specialist assessment and investigations.</li><li>The uncertain evidence of benefit of antibiotic prophylaxis for reducing the risk of recurrent UTI and the rate of deterioration of renal scars.</li><li>The severity and frequency of previous symptoms.</li><li>The risks of long-term antibiotic use.</li><li>The risk of developing complications.</li><li>Previous urine culture and susceptibility results.</li><li>Previous antibiotic use, which may have led to resistant bacteria preferences for antibiotic use.</li></ul></li><li><strong>When a trial of daily antibiotic prophylaxis is given, provide advice about:</strong><ul><li>The risk of resistance with long-term antibiotics, which means they may be less effective in the future.</li><li>Possible adverse effects of long-term antibiotics.</li><li>Returning for review within 6 months.</li><li>Seeking medical help if there are symptoms of an acute UTI.</li></ul></li><li><strong>Arrange ultrasound of the urinary tract:</strong><ul><li>During the acute infection for children aged under 6 months with recurrent UTI.</li><li>Within 6 weeks for children aged 6 months and over with recurrent UTI.</li></ul></li><li><strong>Ensure that a dimercaptosuccinic acid scintigraphy (DMSA) scan to detect renal parenchymal defects is carried out within 4–6 months following the acute infection in all children with recurrent UTI.</strong><ul><li>This investigation should be arranged by paediatric specialists when appropriate. </li></ul></li><li><strong>Refer all children with recurrent UTI to a paediatric specialist for assessment and investigations.</strong></li></ul><!-- end field 3f69d0c8-10e4-4048-a12f-a9ed010ec405 --><!-- end item b643f987-2e69-47c2-ab8c-a9ed010ec404 -->","subChapters":[{"id":"f5b568d4-8e30-58d3-bdcb-d6568817ec3b","slug":"antibiotic-prophylaxis","fullItemName":"Antibiotic prophylaxis","depth":4,"htmlHeader":"<!-- begin field 3f5ce794-730c-4759-be38-a9ed0112bccb --><h4>Antibiotic prophylaxis</h4><!-- end field 3f5ce794-730c-4759-be38-a9ed0112bccb -->","summary":null,"htmlStringContent":"<!-- begin item 0dbeb562-53fe-4536-a167-a9ed0112bca2 --><!-- begin field 296cf221-ad6d-43bc-ad64-a9ed0112bccb --><ul><li><strong>Do not prescribe antibiotic prophylaxis routinely for children following first-time urinary tract infection (UTI).</strong></li><li>When prescribing antibiotic prophylaxis for children with recurrent UTI, take account of local antimicrobial resistance data. Preferred treatment options are: <ul><li>Trimethoprim. For children aged:<ul><li>3–5 months — 2 mg/kg at night (maximum 100 mg per dose) or 12.5 mg at night.</li><li>6 months to 5 years — 2 mg/kg at night (maximum 100 mg per dose) or 25 mg at night.</li><li>6–11 years — 2 mg/kg at night (maximum 100 mg per dose) or 50 mg at night.</li><li>12–15 years — 100 mg at night.</li></ul></li><li>Nitrofurantoin (if eGFR ≥ 45ml/minute). For children aged:<ul><li>3 months to 11 years — 1 mg/kg at night.</li><li>12–15 years — 50–100 mg at night.</li></ul></li></ul></li><li>If these are unsuitable, or inappropriate, second-line options are:<ul><li>Cefalexin. For children 3 months to 15 years — 12.5 mg/kg at night (maximum 125 mg per dose).</li><li>Amoxicillin. For children aged:<ul><li>3 months to 11 years — 62.5 mg at night.</li><li>1–4 years — 125 mg at night.</li><li>5–15 years — 250 mg at night.</li></ul></li></ul></li><li>Review antibiotic prophylaxis for recurrent UTI at least every 6 months:<ul><li>Assess the success of prophylaxis.</li><li>Discuss continuing, stopping or changing prophylaxis (taking into account the person's preferences for antibiotic use and the risk of antimicrobial resistance).</li><li>Remind the parents/carers about behavioural and personal hygiene measures and self-care treatments.</li></ul></li><li>If antibiotic prophylaxis is stopped, ensure that the child has rapid access to treatment if they have an acute UTI.</li></ul><!-- end field 296cf221-ad6d-43bc-ad64-a9ed0112bccb --><!-- end item 0dbeb562-53fe-4536-a167-a9ed0112bca2 -->","subChapters":[]},{"id":"84d24b93-7058-5d03-869a-713f2a61604a","slug":"basis-for-recommendation-e70","fullItemName":"Basis for recommendation","depth":4,"htmlHeader":"<!-- begin field 904d66ac-2771-4ca8-adb4-a9ed010ec406 --><h4>Basis for recommendation</h4><!-- end field 904d66ac-2771-4ca8-adb4-a9ed010ec406 -->","summary":null,"htmlStringContent":"<!-- begin item e70d5515-215b-4c49-a4d9-a9ed010ec406 --><!-- begin field fb9919bc-fd32-4c8e-a274-a9ed010ec406 --><p>These recommendations are based on the National Institute for Health and Care Excellence (NICE) guidelines <em>Urinary tract infection (recurrent): antimicrobial prescribing </em>[<a class=\"bibliography-reference internal-reference\" href=\"/topics/urinary-tract-infection-children/references/\">NICE, 2018e</a>], and <em>Urinary tract infection in children: diagnosis, treatment and long-term management</em> [<a class=\"bibliography-reference internal-reference\" href=\"/topics/urinary-tract-infection-children/references/\">NICE, 2018a</a>].</p><h5>Specialist referral</h5><ul><li>NICE recommends that as part of follow-up for children with recurrent UTI they should be referred to a paediatric specialist for assessment and investigations [<a class=\"bibliography-reference internal-reference\" href=\"/topics/urinary-tract-infection-children/references/\">NICE, 2018a</a>]. </li></ul><!-- end field fb9919bc-fd32-4c8e-a274-a9ed010ec406 --><!-- end item e70d5515-215b-4c49-a4d9-a9ed010ec406 -->","subChapters":[]}]}]}}},"staticQueryHashes":["3666801979"]}